In a significant development, former Spain international footballer Gerard Piqué has been penalized by Spain’s National Securities Market Commission (CNMV) for insider trading. The regulator imposed a fine of up to 200,000 euros on Piqué for utilizing confidential information related to Atrys Health’s planned acquisition of Aspy Global Services in 2021. This case highlights the strict enforcement of market regulations to maintain fair trading practices.
Alongside Piqué, Francisco Jose Elias was also fined 100,000 euros for unlawfully sharing sensitive information about the acquisition deal. The CNMV investigation revealed that Piqué purchased 104,166 shares of Aspy on January 20, 2021, just two days before the acquisition talks were publicly announced. This timing allowed him to benefit from non-public information, which is prohibited under insider trading laws.
Following the public disclosure of the acquisition, Aspy’s share price increased from 2.36 euros on January 20 to 2.80 euros on January 27, 2021. Piqué sold his shares on the latter date, securing an estimated profit of approximately 45,800 euros. The CNMV’s sanctions, issued on April 22, mark the conclusion of the administrative proceedings, although both individuals retain the right to appeal the decision before Spain’s National Court.
This case underscores the vigilance of financial regulators in Spain to deter insider trading and uphold market integrity. It also serves as a reminder that even high-profile figures are subject to the same legal standards as other market participants. The outcome may influence future compliance and transparency efforts within Spain’s financial markets.
